XML 36 R4.htm IDEA: XBRL DOCUMENT v2.4.1.9
STATEMENTS OF OPERATIONS (USD $)
In Thousands, except Share data, unless otherwise specified
3 Months Ended
Mar. 31, 2015
Mar. 31, 2014
Research contract revenue $ 272us-gaap_ContractsRevenue $ 200us-gaap_ContractsRevenue
Operating expenses:    
Research and development, including costs of research contracts 74,249us-gaap_ResearchAndDevelopmentExpense 6,542us-gaap_ResearchAndDevelopmentExpense
General and administrative 4,250us-gaap_GeneralAndAdministrativeExpense 3,442us-gaap_GeneralAndAdministrativeExpense
Total operating expenses 78,499us-gaap_OperatingCostsAndExpenses 9,984us-gaap_OperatingCostsAndExpenses
Loss from operations (78,227)us-gaap_OperatingIncomeLoss (9,784)us-gaap_OperatingIncomeLoss
Other income (expense), net (4)us-gaap_OtherNonoperatingIncomeExpense (9)us-gaap_OtherNonoperatingIncomeExpense
Change in fair value of warrants   82us-gaap_UnrealizedGainLossOnDerivatives
Net loss $ (78,231)us-gaap_NetIncomeLoss $ (9,711)us-gaap_NetIncomeLoss
Net loss per share-basic and diluted $ (0.69)us-gaap_EarningsPerShareBasicAndDiluted $ (0.10)us-gaap_EarningsPerShareBasicAndDiluted
Weighted average common shares outstanding used to compute net loss per share-basic and diluted 113,410,250us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted 100,229,200us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted